While no medication has consistently proven effective for Visual Snow Syndrome (VSS), various options have been studied in hopes of relieving symptoms. Below are the medications researched, their intended effects, and the outcomes observed among VSS patients. Although a few individuals experienced slight relief, overall results have been mixed, with many patients seeing little to no improvement or experiencing side effects, including worsening of symptoms or, in some cases, the onset of new VSS symptoms. Many VSS patients have also expressed that they attribute the use of various medications, including the following, to the onset of their condition. Even if they have provided relief for some, these medications have also allegedly been linked to the onset of VSS or increased symptoms in other cases. No single medication has had the same effect on everyone with VSS, nor do these medications help everyone. Otherwise, every VSS patient who took them would have experienced improvements or the same effects and treating VSS would be definitive, which is not to this date.
It is imperative to consult a qualified medical professional, ideally with knowledge of VSS such as those in our Visual Snow Doctors & Specialists Directory, to ensure safety and determine what is best for you based on your specific symptoms and personal medical history.
This site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed healthcare professional. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this site or its use.
Lamotrigine: An anticonvulsant typically used for seizure control and mood stabilization. It provided limited improvement for a few VSS patients but was generally ineffective. In some cases, it worsened symptoms, suggesting it does not address the underlying visual processing disruptions of VSS. The best data available shows lamotrigine being effective in 8 out of 36 cases (22%).
Topiramate: Commonly prescribed for migraine prevention and seizure disorders. Results were mixed, with some patients reporting slight improvement, while others experienced worsened symptoms, including increased VSS severity. Side effects were often severe enough to outweigh any minor benefits. Data indicate that topiramate was effective in 2 out of 13 cases (15.4%).